Sign In
Get Clay Free →

Suggestions

    Stig Hansen

    Co-founder, President, and CEO, Kimia Therapeutics, Inc.

    Stig Hansen is an accomplished professional with a strong educational background in Molecular Biology, Neuroscience, and Biochemistry.

    He studied for his Post-Doc and Visiting Scholar in Molecular Biology and Neuroscience at the University of California, Berkeley, further enhancing his expertise in the field.

    Prior to this, Stig Hansen pursued his Ph.D. in Molecular and Cell Biology at Københavns Universitet - University of Copenhagen, and obtained his Master of Science in Biochemistry from the same esteemed institution.

    Stig Hansen has held key positions in various prominent organizations, showcasing his leadership and strategic skills.

    He was the Co-founder, President, and CEO at Kimia Therapeutics, demonstrating his entrepreneurial spirit and ability to drive success in the industry.

    Additionally, he served as a Member of the Board of Directors, as well as the Co-founder and CEO, at Carmot Therapeutics, Inc., illustrating his versatile capabilities in different roles within the biotech sector.

    His professional journey also includes the role of Associate Director of Biology at Sunesis Pharmaceuticals, adding to his rich experience and expertise in the pharmaceutical industry.

    Stig Hansen
    Add to my network

    Location

    Berkeley, California, United States